Applying pharmacokinetic/pharmacodynamic principles for optimizing antimicrobial therapy during continuous renal...

Area of Science:

• Nephrology
• Critical Care Medicine
• Clinical Pharmacy

Background:

• Continuous renal replacement therapy (CRRT) is increasingly used in intensive care units, often replacing intermittent hemodialysis (IHD).
• While CRRT improves hemodynamic and metabolic stability, its impact on drug clearance, particularly antimicrobials, is a growing concern.
• Existing antimicrobial dosing guidelines for IHD may lead to inadequate drug levels in CRRT patients, risking treatment failure and antimicrobial resistance.

Purpose of the Study:

• To review the impact of CRRT on antimicrobial pharmacokinetics and pharmacodynamics.
• To provide evidence-based antimicrobial dosing recommendations for patients undergoing CRRT.
• To highlight the importance of pharmacokinetic/pharmacodynamic principles in optimizing antimicrobial therapy during CRRT.

Main Methods:

• Systematic review of the literature on CRRT and antimicrobial dosing.
• Analysis of pharmacokinetic/pharmacodynamic properties of commonly used intensive care antimicrobials.
• Development of revised dosing recommendations for CRRT patients based on drug characteristics.

Main Results:

• Antimicrobial dosing regimens optimized for IHD often result in significant underdosing during CRRT.
• Pharmacokinetic/pharmacodynamic principles are crucial for achieving therapeutic drug concentrations in CRRT patients.
• Specific dosing adjustments are proposed for various antimicrobials based on their properties and CRRT modality.

Conclusions:

• Optimized antimicrobial dosing is essential during CRRT to ensure treatment efficacy and prevent resistance.
• Pharmacokinetic/pharmacodynamic-guided dosing and therapeutic drug monitoring, where feasible, are recommended for critically ill patients on CRRT.
• Further research and clinical guidelines are needed to refine antimicrobial management in the CRRT population.